Showing results (181-190 of 250) with videos related to

Sort By:
Pageof 25
Fundamental & Clinical Pharmacology|October 9, 2012
Sitagliptin added to previously taken antidiabetic agents on insulin resistance and lipid profile: a 2-year study evaluationGiuseppe Derosa, Pietro Dario Ragonesi, Elena Fogari, et al.
Clinical Therapeutics|July 10, 2007
Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trialGiuseppe Derosa, Arrigo F G Cicero, Angela D'Angelo, et al.
Diabetes Research and Clinical Practice|September 29, 2005
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitusGiuseppe Derosa, Maria A Avanzini, Diego Geroldi, et al.
European Journal of Pharmacology|December 2, 2010
Acarbose actions on insulin resistance and inflammatory parameters during an oral fat loadGiuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, et al.
Diabetes/Metabolism Research and Reviews|October 24, 2019
Glyco-metabolic control, inflammation markers, and cardiovascular outcomes in type 1 and type 2 diabetic patients on insulin pump or multiple daily injection (italico study)Giuseppe Derosa, Gabriele Catena, Laura Scelsi, et al.
Clinical Therapeutics|June 29, 2004
Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trialGiuseppe Derosa, Arrigo F G Cicero, Antonio Gaddi, et al.
Metabolism: Clinical and Experimental|October 23, 2008
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazoneGiuseppe Derosa, Angela D'Angelo, Sibilla A T Salvadeo, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 15, 2021
Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CVMatthew J Budoff, Timothy M E Davis, Alexandra G Palmer, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 26, 2010
Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditisMassimo Imazio, Antonio Brucato, Bongani M Mayosi, et al.
British Journal of Clinical Pharmacology|December 2, 2015
Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trialsAmirhossein Sahebkar, Luis E Simental-Mendía, Claudio Pedone, et al.
Pageof 25